Hi Catherine,
The results are in, and I am a bit relieved because I think they are more positive than negative:
“Increased metabolic activity in the area of mediastinal lymph nodes which most probably is result of pseudoprogression or sarcoidosis /as a side effect from treatment/, but possible disease progression could not be completely excluded.”
There is still some uncertainty, but I am very positive that it is a side effect of treatment. Now I am more convinced she is getting spartalizumab, not the placebo.